Acceleron Pharma Inc
Change company Symbol lookup
Select an option...
XLRN Acceleron Pharma Inc
CLZNY Clariant AG
CARR Carrier Global Corp
KBH KB Home
SMIT Schmitt Industries Inc
OOMA Ooma Inc
SEDG Solaredge Technologies Inc
CELH Celsius Holdings Inc
BABA Alibaba Group Holding Ltd
CS Credit Suisse Group AG
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Acceleron Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its research focuses on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta (TGF-beta), protein superfamily. It has four internally discovered therapeutic candidates that are in clinical trials, which include luspatercept, sotatercept, dalantercept and ACE-083. It offers a platform technology, IntelliTrap. It is also evaluating ACE-1332, a selective TGF-beta antagonist, for treatment of disorders with a fibrotic component, and additional molecules from its IntelliTrap platform for undisclosed therapeutic areas. Dalantercept is designed to treat cancers by inhibiting blood vessel formation by inhibiting signaling through the ALK1 receptor. ACE-083 is designed to promote muscle growth and function in specific, targeted muscles.

Closing Price
$117.75
Day's Change
4.00 (3.52%)
Bid
--
Ask
--
B/A Size
--
Day's High
117.75
Day's Low
113.79
Volume
(Average)
Volume:
255,048

10-day average volume:
233,123
255,048
  • Prev Close
    113.75
  • Today's Open
    114.47
  • Day's Range
    113.79-117.75
  • Avg Vol (10-day)
    233.1K
  • Last (time)
    1:00p ET 11/27/20
  • Last (size)
    59
  • 52-Wk Range
    46.00 - 124.01
    LowHigh
  • (12/06/19 - 10/13/20)
    5.05%
  • 66.6%
  • Market Cap
    7.1B
  • Shares Outstanding
    60.3M
  • -2.40
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.5
  • 88.89
  • (% of float 11/15/20)
    6.69

Latest News

November 13, 2020
7:01 am ET
BusinessWire
7:00 am ET
BusinessWire
November 09, 2020
4:00 am ET
BusinessWire
November 05, 2020
4:17 pm ET
Accesswire
1:01 pm ET
BusinessWire
4:15 am ET
BusinessWire
November 04, 2020
1:01 pm ET
BusinessWire
October 26, 2020
7:00 am ET
BusinessWire
September 29, 2020
6:59 am ET
BusinessWire
September 17, 2020
4:01 pm ET
BusinessWire
September 16, 2020
7:00 am ET
BusinessWire
August 25, 2020
8:14 am ET
MarketWatch
June 24, 2020
4:29 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.